This meta-analysis evaluated the efficacy and safety of periprostatic nerve block (PPNB) and intrarectal local anesthestic (IRLA) gel in alleviating pain during prostate biopsy. Electronic databases MEDLINE, Cochrane Central Register of Controlled Trials and EMBASE were searched to identify all randomized controlled trials comparing PPNB with periprostatic placebo injection, no injection or with IRLA. Studies for inclusion were identified and extracted by two authors independently. The main outcome measure was patients' assessment of mean pain scores on a 10-point scale at the end of the biopsy procedure. Secondary outcomes were complications and adverse events. Continuous data from the trials were combined by calculating the weighted mean difference (WMD) with its 95% confidence interval. In total, 25 studies met the inclusion criteria. Twenty studies involving 1685 patients compared PPNB with either no anesthesia or with placebo injection controls, showing a significant reduction in pain score in the anesthetic group (WMD À2.09, 95% CI À2.44 to À1.75, Po0.00001). Five studies with 466 patients compared IRLA and control. Although IRLA was associated with pain reduction, the effect size was not statistically significant (WMD À0.22, 95% CI À0.56 to 0.12). Six studies with 872 patients compared PPNB with IRLA, showing a significant pain reduction in the former group (WMD À1.53, 95% CI À2.67 to À0.39, P ¼ 0.008). No trials reported an increase in complications in the treatment arms. In conclusion, the evidence from randomized controlled trials shows that local anesthetic given as a PPNB, but not as an intrarectal instillation, is effective and safe in alleviating pain from transrectal ultrasound biopsy of the prostate.
Introduction
Although transrectal ultrasound-guided biopsy of the prostate was initially thought to be well tolerated by most patients, 1 recent reviews have shown that between 65 and 90% of patients report discomfort during the procedure and up to 30% of patients have significant pain.
2, 3 Irani et al. 4 reported that 6% of patients judged that the procedure should have been performed under general anesthesia, whereas 19% would not agree to undergo the procedure again without some form of anesthesia.
When pain is severe, it may result in decreased accuracy owing to excessive patient movements or decreased number of planned biopsies. 5 There is now evidence that increasing the number of biopsies and repeat biopsies can increase the detection rate of prostate cancer, 6, 7 with some urologists advocating saturation needle biopsies, 8, 9 further increasing the need for anesthesia. In addition, pain control is particularly important in the setting of prostate cancer screening with prostate-specific antigen (PSA) testing. In this context, large numbers of patients who are identified as having high risk of cancer with increased PSA concentration will require biopsy. Unless these investigations are tolerable, patients will not accept them. 10 Recent surveys showed that few urologists use any form of local anesthesia during prostate biopsy. [11] [12] [13] Periprostatic nerve block (PPNB) was first adapted for transrectal ultrasound-guided biopsy of the prostate by Nash et al.
14 in 1996, but it was not until 2000 that Soloway and Obek 12 further modified and popularized the technique. In addition, Desgrandchamps et al. 15 and Issa et al. 16 provided early conflicting reports on the use of intrarectal lignocaine gel (IRLA) before prostate biopsy. Since then, there has been greater awareness of the need for pain relief with increasing number of publications on this subject. 17 Hence, the objective of this meta-analysis of all randomized controlled trials was to evaluate the efficacy and safety of PPNB and IRLA gel in alleviating pain during prostate biopsy. were searched to identify all published randomized controlled trials comparing PPNB with periprostatic placebo injection, no injection or with IRLA. Reference lists of the retrieved studies were also checked for any relevant trials. Unpublished data and additional information were requested from the individual authors by personal communication. No language restriction was made during the search. Duplicate references were excluded. However, if the selected studies had followup publications with relevant data, they were considered for the analysis. The search terms used were: Anesthesia; Anesthetics, Local; Prostate Biopsy.
Methods

Search strategy
Study description and validity
For the methods of data extraction, statistical analysis and reporting, the principles of QUOROM (Quality of Reporting of Meta-analysis) were followed. 18 The literature search was screened and by consensus the relevant articles were obtained and reviewed. Two independent reviewers identified trials for inclusion and assessed the quality of trials (method of randomization, level of concealment of allocation, degree of blinding, intention to treat) and the homogeneity of trial patients.
Data extraction
All available published data on pain measurements for patients undergoing transrectal ultrasound-guided biopsy of the prostate were selected for analysis, provided that the data source was a prospective randomized controlled clinical trial, and that the study design included the comparisons of the efficacy of PPNB or IRLA with placebo injection, with no anesthesia or with each other. In addition, the treatment doses and route of local anesthesia administration were also reported in the included studies. The data were extracted independently and in duplicate with any difference in opinion resolved by consensus.
The primary outcome measures extracted were the mean overall pain scores from the biopsy procedure, measured on a linear pain scale and their standard deviations. The majority of studies utilized a 10-point visual analog scale (0 -no pain, 10 -maximum pain). In two studies, a five-point pain scale was used and the scores in these studies were converted to a 10-point pain scale to facilitate comparison. 14, 19 If the pain ratings in a study were taken at different times of the biopsy procedure, only the pain scores taken immediately at the end of the biopsy procedure were extracted for analysis. The secondary outcome measures were complications associated with the use of local anesthesia.
Statistical analysis
Statistical analysis was carried out using the Review Manager Version 4.2.7 (Cochrane Collaboration, Update Software, UK). Continuous data from the trials were combined by calculating the weighted mean difference (WMD) with its 95% confidence interval (CI). To quantify the effect of result heterogeneity, I
2 heterogeneity test was used. A random effects model was used to pool the data if I 2 value was greater than 50%, and if the result was homogeneous a fixed-effects model was used. If data on mean pain scores and their standard deviation were not obtainable from the study or by direct communication, the trial was not included in the pooled meta-analysis.
Results
Study selection
From an initial number of 61 publications identified from the search strategy, 19 were excluded as irrelevant ( Figure 1) . Hence, the remaining 42 publications, which potentially met the selection criteria, were retrieved for detailed evaluation. From this pool, 17 publications were further excluded from analysis for the following reasons. The trials were ineligible in seven studies because they were single arm or nonrandomized studies, 12, [20] [21] [22] had small patient numbers (o10) within each study arm 23 or had used a non-validated or categorical pain scale. 15, 24 Eight studies were excluded because complete data on the mean or standard deviation of the pain scores of the patients was not provided or obtainable. 16, [25] [26] [27] [28] [29] [30] [31] Two studies were excluded as they were duplicates. 32, 33 A total of 25 trials were eventually evaluated. 19, 56, 57 Trials identified as potentially relevant and screened (n= 61) Trials retrieved for detailed evaluation (n=42) Trials excluded as not relevant (n=19)
Trials included in meta-analysis (n=25)
Trials not meeting selection criteria and excluded (n=17) Figure 1 Flow diagram of trial selection process.
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All included trials were published as full reports in journals.
Study description and validity
The characteristics of the 25 included trials are given in Figure 2 . Randomization methods were judged to be adequate in 10 studies. [34] [35] [36] 42, 44, [51] [52] [53] 19, 56 They were not specified in the remaining 15 trials. 14, [37] [38] [39] [40] [41] 43, [45] [46] [47] [48] [49] [50] 54, 55 For the trials assessing the efficacy of PPNBs, two types of controls were used. Either no anesthesia at all was given or an equivalent volume of normal saline injection was administered. Trials that used placebo injections as controls were double-blinded, whereas trials that used no anesthesia as controls had no concealment of treatment allocation. For the 10 trials with placebo injections, concealment of allocation was judged to be adequate with central office randomization in six studies, 35, 42, 46, 55, 19, 56 but was not used or unclear in the remaining four. 14, 40, 47, 48 For these 10 studies, there was also concern that normal saline placebo injections may cause additional injection-related pain 41 and pain scores from placebo injections alone had been measured to be between 1.1 and 1.8. 51 To address this issue, both types of study controls (no anesthesia as well as placebo injection) were used in two of the studies and no significant difference was found between the mean pain scores of the placebo injection groups and the no anesthesia control groups. 14, 40 For these two studies, only data between the PPNB and placebo injection Figure 2 Trial and patient characteristics.
Transrectal ultrasound-guided biopsy of the prostate HY Tiong et al arms were extracted for the meta-analysis to prevent duplication of data in the analysis from the study groups. Hence, in total, at least 3143 patients were randomized in these 25 trials with 2739 of the patients evaluable.
In addition, different techniques of PPNB were described in the included trials. By consensus, these were broadly categorized into five main techniques as shown in Figure 2 . Different volumes, concentration and types of local anesthesia had also been used (Figure 2) . In two trials assessing PPNB, different volumes 46 and different techniques 51 of local anesthesia were used. In both trials, the mean pain scores for the technique and volume with the optimum results were selected for comparison.
For the trials assessing the efficacy of IRLA gel, treatment arms were again compared to either no anesthesia used or placebo gel control. In three of the studies, all three arms (control, IRLA gel, PPNB) were included for comparisons. 34, 53, 54 Appropriate data from each publication was extracted for the meta-analysis to facilitate comparisons between the arms. Lastly, the patients in the studies also varied according to the number of biopsies taken. Overall, an average of between 6 and 12 cores biopsies were performed for these patients as shown in Figure 2 .
Comparisons Figure 3 shows the forest plot comparing PPNB with either no anesthesia or with placebo injection controls. Ten studies involving 917 patients compared PPNB with no anesthetic given. Ten studies involving 768 patients compared PPNB with a placebo injection. Patients with PPNB had significantly lower pain scores from prostate biopsies compared to those with placebo injections (WMD À1.96, 95% CI À2.40 to À1.53) or with no analgesia (WMD À2.09, 95% CI À2.44 to À1.75), using the random effects model owing to significant result heterogeneity. Figure 4 shows Figure 5 shows the forest plot comparing patients with PPNB with different dosages (o10 ml of 1% Lidoocaine (WMD À1.97, 95% CI À2.56 to À1.38), 10 ml of 1% Lidocaine/Artacaine/Carbocaine (WMD À2.13, 95% CI À2.83 to À1.42), 5 ml of 2% Lidocaine (WMD À2.06, 95% CI À2.70 to À1.42), 10 ml Figure 7 shows the forest plot comparing IRLA and control (placebo gel or no anesthesia). In total, there were five studies with 466 patients. Although the pain score was less in patients given local anesthesia (WMD À0.22, 95% CI À0.56 to 0.12), the difference was not statistically significant (Z ¼ 1.29, P ¼ 0.2) Figure 8 shows the forest plot comparing PPNB with IRLA. Six studies involving 872 patients compared local anesthetic injection versus IRLA gel. The overall treatment effect shows that the pain score was significantly less in patients given local anesthetic injection compared to IRLA gel (WMD À1.53, 95% À2.67 to À0.39) (random effects model).
Not all studies reported their complication rates. For those that did, there was no reported increase in complications in terms of hematospermia, hematuria, bleeding per rectum, sepsis and local anesthetic toxicity for the treatment arms of PPNB when compared to controls, as shown in Figure 9 .
Discussion
Currently, PPNB and IRLA are the most extensively studied methods of administration of local anesthesia for pain relief during transrectal ultrasound-guided biopsy of the prostate. 17 
Periprostatic nerve block
This meta-analysis shows that local anesthesia, given as a PPNB, significantly reduces the pain arising from transrectal ultrasound-guided prostate biopsy when compared with no anesthesia, placebo and intrarectal instillation of local anesthesia. Sensory fibers from the prostatic capsule convey pain sensation via ramifications within the prostatic plexus, which subsequently travel with the prostatic vascular pedicles at the posterolateral border of the prostate. 57 Infiltration of the local anesthesia around these neurovascular bundles achieves its anesthetic effect. Nash et al. 14 initially described the technique of single local anesthestic injection, on each side of the prostate, into the region of the prostatic pedicle at the base of the prostate just lateral to the junction between the prostate and seminal vesicles. This posterolateral area of fat within the notch between the prostate and seminal vesicle creates a hyperechoic pyramid, which was termed as the 'Mount Everest' sign by Jones et al. to facilitate localization. 20, 26, 49 Soloway and Obek 12 later modified the technique by placing two further depot injections on each side of the prostate on the lateral aspect. 22 On the other hand, Seymour et al. 52 and later Rogriguez et al. 50 performed periprostatic infiltration only at the apex at the 4 and 8 O' clock positions. From the apex, local anesthesia spreads along the posterior aspect of the prostate and seminal vesicles under the Denovillier's fasica, achieving sufficient pain control. 19 Combined local anesthetic injections to both the prostate base and apex have subsequently been studied but have not been shown to be significantly more effective than either technique on its own. 46, 51 However, when local anesthestic injections were given too laterally, either targeted lateral to the tip of seminal vesicles 56 or lateral to the prostate on its transversal images, 55 pain relief is ineffective and these techniques had been criticized to be too far from the neurovascular bundle. 58 Data from this meta-analysis has demonstrated that PPNB reduces pain significantly for patients undergoing between six to 12 biopsies. Jones et al. 20 have indicated that it may be sufficiently effective to perform officebased saturation biopsies. In addition, it can be effective over a wide range of different volumes, concentrations and types of local anesthesia, as used within the studies. Although a dose-response relationship was not demonstrated by this meta-analysis, Ozden et al. 46 showed in Transrectal ultrasound-guided biopsy of the prostate HY Tiong et al their study that 2.5 ml of 1% lidocaine given as a PPNB was probably not effective and 10 ml of 1% lidocaine injections provided significantly better pain control than lower doses. In terms of safety, there were no increased complications from biopsy or adverse events from local anesthetic administration reported in all the studies included in the meta-analysis. In addition, Soloway and Obek 12 and others 22, 36, 40, 52 reported no difference in intraoperative findings such as fibrosis or loss of planes between rectum and prostate in patients who underwent prostate biopsies with and without local anesthetic.
Intrarectal lignocaine
Our results show that intrarectal lignocaine is not significantly better than placebo gel or no local anesthesia in reducing pain during prostate biopsy. Despite this, there are some studies to suggest that it may reduce the pain from probe insertion, due to the presence of pain sensory innervations below the dentate line. 53 In a threeway comparison, Stirling et al. 53 found out that although patients who received local anethesia of any type had significantly lower pain scores than the control group; patients who received IRLA had the lowest scores for probe insertion, but not for biopsy. Some investigators have argued that not all patients require local anesthesia and local anesthetic techniques should be targeted at patients who would most benefit from them. Cross-sectional studies on morbidity of prostate biopsies by Djavan et al. 60 and Rodriguez et al. 59 have concurred that younger patients had a higher discomfort rate. Studies included within this meta-analysis 27, 37, 38 confirm this. Despite the report by Naughton et al. 61 that a 12-core biopsy procedure has no significant difference in pain compared to a 6-core procedure, others have shown that the pain level does increase significantly with increasing number of biopsies. 27, 51 Apical biopsies were also thought to be more painful than biopsies of the prostate base. 27, 51 In the study by Kaver et al., 27 patients with a prostate volume Figure 8 Forest plot comparing PPNB with intrarectal local anesthetic gel.
Complications or Adverse Events associated with periprostatic Study nerve block injection Nash [14] No adverse events occurred in both groups Wu [56] No complications occurred in the study Alavi [36] No complications observed in the study Pareek [48] No significant difference in patient reported incidences (LA vs. CT) of hematuria (73% vs. 73%), hematospermia (67% vs. 63%) or rectal bleeding (46% vs. 33%). Seymour [52] No adverse events from LA injection. No difference in median number of days (LA vs. CT) of hematuria (2.6 vs 2.3), hematochezia (0.55 vs. 0.36), and hematospermia (0.65 vs. 0.69). Knobloch [41] No complications related to injection. No impact on cancer detection rate (LA = 50%, CT = 47.1%). Leibovici [42] 1 patient per group developed septicemia. Walker [19] 1 complication (clot retention) in LA group. Addla [35] No complication due to LA observed. Ozden [46] No significant difference in complications between placebo and increasing amount of local anesthesia or number of injections used. Ozveri [47] No significant difference in incidence (LA vs. CT) in hematuria (30% vs. 26%), hematospermia (28% vs. 24%) and rectal bleeding (18% vs. 12%). Rodriguez [50] No significant difference in adverse events between LA and gel groups. Adamakis [34] No complications related to LA injection. No significant difference between incidence of urethral bleeding (27%, 33%, 22%), hematospermia (30%, 30%, 37%), rectal bleeding (20%, 20%, 17%), infection (2%, 2%, 2%) after the biopsy between CT lidocaine cream and LA groups. Inal [40] No adverse events from LA injection. No significant difference in hematuria and hematochezia between LA and CT. Mallick [43] No difference (LA vs. CT) in hematuria (2% vs. 2%), hematospermia (1% vs. 1%). Vanni [55] No difference in hematuria and rectal bleeding between LA & CT. Nambirajan [44] No significant difference in hematuria (8.4% vs. 10.4%), rectal bleeding (8.4% vs. 6.3%), hematospermia (18.8% vs. 23%) and infection (8.3% vs. 10.4%) between groups (LA vs. CT). Obek [45] Higher rate of complications in periprostatic infiltration but not significantly different. Figure 9 Table showing studies that reported their rates of complications or adverse events from PPNB (LA) when compared to controls (CT).
Transrectal ultrasound-guided biopsy of the prostate HY Tiong et al of less than 50 ml had more pain than those with larger prostates. Patients with a final pathological diagnosis of cancer may suffer less pain than those with benign pathological results. 43 Pre-biopsy anxiety is also thought to be an important factor for increased pain sensation. 42 Further research into these factors will enable urologists to tailor their pain relief regime for each individual patient undergoing prostate biopsy.
Conclusions
Our meta-analysis has shown definitively that local anesthesia given as a PPNB is effective and safe in alleviating pain from transrectal ultrasound biopsy of the prostate. It is effective when administered as a single or multiple posterolateral local anesthetic injection, apex injection or combined posterolateral and apex injections. A range of volumes, concentration and types of local anesthetic can be used and it is effective for 12 and possibly more biopsies. Hence, it should now be the standard of care for patients undergoing transrectal ultrasound-guided prostate biopsy.
